24 24 - Reddy GT, Kumar PM, Veena KM. Formulation and evaluation of alendronate sodium gel for the treatment of bone resorptive lesions in periodontitis. Drug Deliv. 2005;12(4):217-22. (2005). Briefly ...

Sodium alendronate is a bisphosphonate drug that exerts antiresorptive action and is used to treat osteoporosis. Objective The aim of this study was to evaluate the bone repair process at the ...

Each tablet contains sodium alginate IP 500mg and potassium bicarbonate IP 100mg. It is designed to treat symptoms such as acid regurgitation, heartburn, and indigestion, which can occur after ...

New Delhi: Granules India Ltd on Wednesday said it has received approval from the US health regulator for its generic pantoprazole sodium delayed-release tablets used in the short-term treatment ...

by the US Food and Drug Administration (US FDA) for pantoprazole sodium delayed-release tablets USP in both 20 mg and 40 mg strengths. These tablets are identified as bioequivalent and ...

About BINOSTO ®: BINOSTO ® (alendronate sodium) is an effervescent tablet for oral solution indicated for the treatment of osteoporosis in postmenopausal women and treatment to increase bone ...

Here in this work, integrated with simultaneous requirement of preferred scaffold and smart drug formulation ... J&K), methacrylate anhydride (98%, J&K), sodium periodate (NaIO 4, Aladdin), ...